Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|November 5, 2025
Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphomaSara Ekberg, Ingrid Glimelius, Alexandra Albertsson-Lindblad, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 8, 2018
Short- and long-term risks of cardiovascular disease following radiotherapy in rectal cancer in four randomized controlled trials and a population-based registerLingjing Chen, Sandra Eloranta, Anna Martling, et al.
European Journal of Haematology|February 14, 2016
The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in childrenAnnika Englund, Daniel Molin, Gunilla Enblad, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work LossLingjing Chen, Ingrid Glimelius, Martin Neovius, et al.
European Journal of Haematology|May 5, 2018
Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphoma-A population-based study from SwedenMagnus Björkholm, Caroline E Weibull, Sandra Eloranta, et al.
Leukemia & Lymphoma|June 7, 2019
Socioeconomic impact of Hodgkin lymphoma in adult patients: a systematic literature reviewRakel Pálmarsdóttir, Andreas Kiesbye Øvlisen, Marianne Tang Severinsen, et al.
Histopathology|March 8, 2012
Tissue microarray and digital image analysis: a methodological study with special reference to the microenvironment in Hodgkin lymphomaIngrid Glimelius, Fredrik Qvarnström, Martin Simonsson, et al.
European Journal of Haematology|March 8, 2006
IL-9 expression contributes to the cellular composition in Hodgkin lymphomaIngrid Glimelius, Annika Edström, Rose-Marie Amini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2022
Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field RadiotherapyIngemar Lagerlöf, Helena Fohlin, Gunilla Enblad, et al.
Pageof 12